425: Strive CMO Reposts Merger Update with Semler Scientific

Strive's Chief Marketing Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• A communication was reposted on X.com by Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., on December 29, 2025.
• The communication is in connection with Strive's proposed business combination with Semler Scientific, Inc.
• It includes cautionary statements regarding forward-looking statements related to the proposed transaction.
• Forward-looking statements cover the outlook, expectations, strategic and financial benefits, timing of closing, and successful integration of the combined businesses.
• Investors are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC documents for comprehensive information.

Sentiment

Score: 5

Explanation: The filing is neutral, primarily serving as a cautionary statement regarding a proposed business combination and directing readers to further information. It outlines potential benefits but heavily emphasizes numerous risks and uncertainties.

Positives

• Anticipated strategic benefits from the proposed business combination.
• Expected financial benefits from the proposed business combination, including impact on the combined company's future financial performance.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors that could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses.

Management Comments

• Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., reposted the communication on X.com on December 29, 2025.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests the combined entity's strategic direction or exposure to the evolving digital asset industry, aligning with broader trends of corporate adoption of digital assets.

Stakeholder Impact

• Shareholders: Potential dilution for Strive shareholders due to the issuance of additional Class A common stock; Semler Scientific stockholders are urged to vote on the proposed transaction.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential changes to employee relationships.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus regarding the proposed transaction and any other relevant documents filed with the SEC.

Key Dates

Recommendation

This filing is a procedural communication related to a proposed business combination, primarily serving as a cautionary statement about forward-looking information and directing investors to comprehensive merger documents. It does not contain new financial results or operational updates that would significantly alter a fundamental valuation. Investors should hold and await the outcome of the merger and further detailed financial disclosures from the combined entity, while carefully considering the outlined risks.

Keywords

Merger, Acquisition, Business Combination, Strive, Semler Scientific, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury